Review on Use of Hydroxychloroquine and Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Amandeep Singh Rawat ^[2] | Jyoti Kathait ^[2]

Abstract: Coronavirus pandemic is currently a global public health emergency. No effective prophylactic or post-exposure therapy is currently available for COVID-19, although some have been tried. One of such drug is combination of Hydroxychloroquine and Azithromycin. Recent publication shows that Hydroxychloroquine sulphate treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by Azithromycin. However, there is limited information about the use of them in COVID-19.

Keywords: COVID-19, prophylactic, post-exposure, Hydroxychloroquine Sulphate, Azithromycin, viral load

Edition: Volume 9 Issue 4, April 2020,

Pages: 1099 - 1102

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait

Review on Use of Hydroxychloroquine and Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Similar Articles with Keyword 'COVID'

To Study Consumer Awareness and Preference of E-Pharmacy during the COVID Period: With Reference to Coimbatore City

Mental Health during COVID-19 Pandemic